Literature DB >> 15018846

Stem cells as a potential treatment of neurological disorders.

Yu-Tzu Tai1, Clive N Svendsen.   

Abstract

The ability of stem cells to participate in brain repair has been increasingly demonstrated in recent studies. Most investigations have aimed to replace damaged neurons and glia by direct transplantation or recruitment of newly generated cells in the adult. However, functional improvements were often a result of stem cell-induced self-repair and neuroprotection, rather than cell replacement. Thus, a far more pragmatic approach in the short term might be to use stem cells as chaperones for degenerating nervous tissues. Additionally, targeted delivery of therapeutic agents could be achieved by modifying stem cells to release specific drugs at the site of transplantation. Elucidation and exploitation of this new 'stem cell pharmacology' has the potential to revolutionise treatment of neurological diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15018846     DOI: 10.1016/j.coph.2003.09.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  16 in total

Review 1.  The design of clinical trials for cell transplantation into the central nervous system.

Authors:  Pierre Cesaro
Journal:  NeuroRx       Date:  2004-10

Review 2.  Evaluation of neural plasticity in adult stem cells.

Authors:  Jeffrey J Ross; Catherine M Verfaillie
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

3.  Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF.

Authors:  Soshana Behrstock; Allison D Ebert; Sandra Klein; Melanie Schmitt; Jeannette M Moore; Clive N Svendsen
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

4.  Tetramethylpyrazine Promotes Migration of Neural Precursor Cells via Activating the Phosphatidylinositol 3-Kinase Pathway.

Authors:  Xiangying Kong; Micun Zhong; Xiaohui Su; Qingxia Qin; Hongchang Su; Hongye Wan; Cuiling Liu; Jiajia Wu; Hongcai Shang; Yanjun Zhang; Na Lin
Journal:  Mol Neurobiol       Date:  2015-11-28       Impact factor: 5.590

5.  Real time imaging of human progenitor neurogenesis.

Authors:  Thomas M Keenan; Aaron D Nelson; Jeffrey R Grinager; Jarett C Thelen; Clive N Svendsen
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

6.  Aneuploid cells are differentially susceptible to caspase-mediated death during embryonic cerebral cortical development.

Authors:  Suzanne E Peterson; Amy H Yang; Diane M Bushman; Jurjen W Westra; Yun C Yung; Serena Barral; Tetsuji Mutoh; Stevens K Rehen; Jerold Chun
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

7.  Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration.

Authors:  Shaomei Wang; Sergej Girman; Bin Lu; Nicholas Bischoff; Toby Holmes; Rebecca Shearer; Lynda S Wright; Clive N Svendsen; David M Gamm; Raymond D Lund
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

Review 8.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 9.  Regenerative cellular therapies for neurologic diseases.

Authors:  Michael Levy; Nicholas Boulis; Mahendra Rao; Clive N Svendsen
Journal:  Brain Res       Date:  2015-07-31       Impact factor: 3.252

10.  A Subsequent Human Neural Progenitor Transplant into the Degenerate Retina Does Not Compromise Initial Graft Survival or Therapeutic Efficacy.

Authors:  Bin Lu; Yanhua Lin; Yuchun Tsai; Sergey Girman; Grazyna Adamus; Melissa K Jones; Brandon Shelley; Clive N Svendsen; Shaomei Wang
Journal:  Transl Vis Sci Technol       Date:  2015-02-10       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.